Developmental anomalies shed light on cancer biology

Researchers' deepening understanding of how tumors develop could one day provide the basis for preventing various cancers, says an expert.

Related Videos
Related Content

Phase 3 Data for Bimekizumab Shows Well Maintained Response

March 21st 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

FDA Approves Adalimumab-Adaz High-Concentration Formulation

March 21st 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

Skin Barrier 101: Keep Up with What Your Patients Are Reading

March 21st 2023

Oral Ivarmacitinib Demonstrates Significant Atopic Dermatitis Improvement

March 21st 2023

Phase 3 Data for Bimekizumab Shows Well Maintained Response

March 21st 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

FDA Approves Adalimumab-Adaz High-Concentration Formulation

March 21st 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

Skin Barrier 101: Keep Up with What Your Patients Are Reading

March 21st 2023

Oral Ivarmacitinib Demonstrates Significant Atopic Dermatitis Improvement

March 21st 2023

Phase 3 Data for Bimekizumab Shows Well Maintained Response

March 21st 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

FDA Approves Adalimumab-Adaz High-Concentration Formulation

March 21st 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

Skin Barrier 101: Keep Up with What Your Patients Are Reading

March 21st 2023

Oral Ivarmacitinib Demonstrates Significant Atopic Dermatitis Improvement

March 21st 2023
© 2023 MJH Life Sciences

All rights reserved.